Five Stocks to Watch

Five Stocks to Watch

Jessica Amir
Market Strategist

Summary:  Watch our three minute video covering five stocks to watch this week. In no particular order stocks to watch include Dexcom which has become the best-performing stock in the S&P500 this month after announcing its newest glucose wearable device is available globally. Marathon Oil is another to watch which has been rallying after OPEC+ production cuts were announced. Plus what to watch when it comes to JPMorganChase’s results. And why to also keep Rivian and Fortescue Metals on your radar

Here are five stocks to perhaps watch in no particular order 



Dexcom (DXCM)

Dexcom is so far the best performing stock in the S&P500 this month up 24% after announcing its newest glucose wearable device, Dexcom G7 is available globally, to those with diabetes aged 2 years and over. The wearable device is now selling in the UK, Ireland, Germany, Austria, and Hong Kong, with launches to take place soon in New Zealand and South Africa. 

Marathon Oil (MRO)

Marathon Oil is also one of the best performers in the S&P500 so far this month, up 20%. Marathon Oil along with many oil and gas producers have been rallying this month following the Oil price (West Texas Intermediate) moving up 16% in 11 days. It comes as OPEC+ agreed to reduce oil output by 2 million barrels a day from November. So the market is once again dealing with supply fears in the oil market. 

 

JPMorganChase (JPM)

JPMorgan is the 14th biggest US stock among the S&500. It’s due to report third-quarter financial quarter results in the second week of October along with Morgan Stanley (MS) and Citigroup (C). The two key things to watch with banks are their net interest margin and if that’s improving or weakening. Secondly, keep an eye on the quality of the banks' loan books - and if they’ve deteriorated or improved. 

 

Rivian (RIVN)

Rivian announced the EV maker is recalling 13,000 vehicles it delivered to customers, that’s nearly all the vehicles it sold. It comes as the company found a minor structural defect. Even though Rivian says the issue was discovered in seven vehicles, it recalled all out of caution 

Fortescue Metals (FMG)

Fortescue Future Industries, teamed up with fellow ASX-listed company Incitec Pivot (IPL) to convert IPL’s ammonia facility into a hydrogen electrolysis hub. A Final Investment Decision is not expected to be made until 2023. However, its hoped the hub will produce green ammonia, which can be exported, used in fertilizer, or used as a low-carbon fuel source for heavy transport, airports, and ports. 


To find out more head to Saxo. 
Type in the Stock you want. And click on the Overview page for fundamental analysis. 



-


For a global look at markets – tune into our Podcast.



 

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 07

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
  • The rise of populism: Far-right parties will influence the future

    The disheartening cycle of unresolved geopolitical conflicts, the rise of polarizing political parties, and the stagnation of productivity.

    Read article
  • Investing in China: Navigating Q1 amid economic challenges

    Understand China's political landscape in Q4 2023 and the impact on counter-cyclical initiatives, with a focus on the pivotal Q1 2024.

    Read article
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.